Registry of right heart interventions in Berlin
Berlin Registry of Right Heart Interventions
This study looks at how well different treatments for right heart valve problems, like the TriClip and Cardioband, help patients feel better and avoid hospital visits.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 1 site (Berlin) |
| Trial ID | NCT04570163 on ClinicalTrials.gov |
What this trial studies
This study evaluates patients who have undergone interventional therapies for valvular diseases of the right heart, focusing on tricuspid and pulmonary regurgitation. It involves follow-up examinations that include medical history, laboratory measurements, and echocardiograms to assess the impact of these therapies on patient outcomes. The study aims to identify which patient subgroups benefit the most from specific interventional techniques, such as the TriClip and Cardioband. By analyzing endpoints like mortality and heart failure hospitalization, the study seeks to enhance understanding of treatment effectiveness.
Who should consider this trial
Good fit: Ideal candidates are patients over 18 years old who have planned or recently undergone valve interventions for tricuspid or pulmonary regurgitation.
Not a fit: Patients who are unable to consent, those in care, or those who cannot comply with follow-up examinations may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients with right heart valve diseases, enhancing their quality of life and longevity.
How similar studies have performed: Other studies have shown success with similar interventional approaches for right heart diseases, indicating a promising avenue for further investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with planned or recent valve interventions of the right heart (tricuspid regurgitation/ stenosis, pulmonary regurgitation/ stenosis) * \>18 years * Written, documented consent Exclusion Criteria: * Patients in care or unable to consent * Patients who are unable to comply with follow-up examinations * Patients who are detained in an institution
Where this trial is running
Berlin
- Charité - Universitätsmedizin Berlin — Berlin, Germany (Recruiting)
Study contacts
- Study coordinator: Henryk Dreger, Prof. Dr. med.
- Email: henryk.dreger@charite.de
- Phone: +4930450613496
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.